Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 32(3); 2008 > Article
Original Article Adiponectin Concentrations in Type 2 Diabetic Patients with or without Metabolic Syndrome.
Ja Young Park, Ja Won Kim, Ji Min Kim, Ying Han, Soo Kyung Park, Ji Young Mok, Mi Kyoung Park, Hye Jeong Lee, Duk Kyu Kim
Diabetes & Metabolism Journal 2008;32(3):224-235
DOI: https://doi.org/10.4093/kdj.2008.32.3.224
Published online: June 1, 2008
  • 2,376 Views
  • 20 Download
  • 5 Crossref
  • 0 Scopus
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Dong-A University Medical Center, Korea.
2Department of Pharmacology, College of Medicine, Dong-A University, Korea.
3Department of Medicine, Dong-A University Graduate School, Korea.
4Diabetes Center, Dong-A University Medical Sciences Research Institute, Korea.
5Department of Internal Medicine, Hyosung City Hospital, Korea.
6Department of Internal Medicine, Hanseo Hospital, Korea.

BACKGROUND
Adipocytes produce several adipokines that modulate insulin action as well as glucose and lipid metabolism. The aim of this study was to evaluate the relationship between serum adiponectin concentrations and metabolic syndrome (MS) in patients with type 2 diabetes mellitus. METHODS: This study included 127 type 2 diabetic patients (males 63, females 64). The subjects were divided into two groups as with or without metabolic syndrome (MS(+) or MS(-)). The MS was diagnosed by International Diabetes Federation. Serum adiponectin, leptin, fasting plasma insulin, glucose, glycated hemoglobin, lipid profile, white blood corpuscle (WBC), aspartate aminotransferase (AST), alanine aminotransferase (ALT), uric acid and C-reactive protein (CRP) were examined. RESULTS: Serum adiponectin concentrations were significantly lower in MS(+) than MS(-) (4.8 +/- 2.4 microgram/mL vs 7.6 +/- 5.8 microgram/mL, 7.6 +/- 3.7 microgram/mL vs 11.5 +/- 7.2 microgram/mL, P < 0.05 in males and females). After adjustment for age and body mass index (BMI), in MS (+), the serum levels of adiponectin correlated positively with high density lipoprotein - cholesterol (HDL-C) and negatively with height, body weight, ALT and CRP. In MS(-), the serum levels of adiponectin correlated positively with HDL-C and negatively with diastolic blood pressure (DBP), triglyceride and CRP. By multiple regression analysis, no parameters were independently correlated with serum adiponectin concentrations in MS(+), while DBP and HDL-C were independently related to serum adiponectin concentrations in MS(-). CONCLUSION: Serum adiponectin concentrations were lower in type 2 diabetic patients with MS than without MS. There were no significant parameters related to decrease serum adiponectin concentrations in MS. But further study is needed to confirm this result.

  • Cite
    CITE
    export Copy
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Adiponectin Concentrations in Type 2 Diabetic Patients with or without Metabolic Syndrome.
    Korean Diabetes J. 2008;32(3):224-235.   Published online June 1, 2008
    Close
Related articles

Diabetes Metab J : Diabetes & Metabolism Journal